Health
Cutting edge synthetic peptides block SARS-CoV-2 (COVID-19) – News-Medical.Net
Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to…
Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells.
The team’s SARS-BLOCK™ peptides competitively inhibit the receptor-binding domain (RBD) on the SARS-CoV-2 spike protein – the surface structure that binds the host cell angiotensin-converting enzyme 2 (ACE2) receptor, to…
-
General20 hours agoAbattoir worker in serious condition after workplace accident in Echuca
-
General21 hours agoWoman who reported NSW MP Gareth Ward’s alleged sex crimes cross-examined
-
Noosa News11 hours agoFull house as Minister shares vision for Sunshine Coast transport
-
General11 hours agoWill AI solve our productivity problem or increase unemployment?